Concepedia

M. Mayenga

MM

Statistics

Publications

4

Citations

97

H-Index

4

Active since

2018

Affiliations

Hôpital Foch(Current)

Inserm

Assistance Publique – Hôpitaux de Paris

M. Mayenga is an author at Hôpital Foch specializing in medicine, lung cancer, and pharmacology.

Publications per year

2018–2023

4

Publications

4

Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases

M. Mayenga, Jean‐Baptiste Assié, I. Monnet et al. · Lung Cancer · 2020 · 47 citations

Medicine, Molecular Genetics, Oncology +13

Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%

Elvire Pons‐Tostivint, P. Hulo, V. Guardiolle et al. · Cancer Immunology Immunotherapy · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +7

Lorlatinib – Induced pulmonary arterial hypertension

Alexandre Chabrol, M. Mayenga, Abdul Momen Hamid et al. · Lung Cancer · 2018 · 14 citations

Medicine, Pharmacology, Pharmacotherapy +7

Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued

M. Mayenga, Nicolas Falvo, Isabelle Mahé et al. · Cancers · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4